|
Dec 8
|
Biotech Deals Are Heating Up. Why 2024 Could Be Even Hotter for M&A.
|
|
Dec 8
|
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
|
|
Dec 8
|
3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows
|
|
Dec 8
|
$19 Billion in a Week: AbbVie Makes Two Big Bets
|
|
Dec 8
|
Should You Be Impressed By AbbVie Inc.'s (NYSE:ABBV) ROE?
|
|
Dec 8
|
The Zacks Analyst Blog Highlights AbbVie, NIKE, BHP Group, CME Group and Block
|
|
Dec 8
|
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?
|
|
Dec 8
|
Hawaiian acquired by Alaska Air, AbbVie boasters portfolio: 4 big deal reports
|
|
Dec 8
|
Stock market today: Wall Street hits 2023 high as it mulls whether economy is too warm or just right
|
|
Dec 7
|
AbbVie Buys Cerevel Therapeutics for $8.7B, Bolstering Neuroscience Portfolio
|
|
Dec 7
|
Bain Capital Banks Massive Return on Cerevel Deal
|
|
Dec 7
|
Top Stock Reports for AbbVie, NIKE & BHP
|
|
Dec 7
|
FTC warns pharma companies on excessive drug patenting
|
|
Dec 7
|
AbbVie's $8.7 billion bet on Cerevel is risky but smart, analysts say
|
|
Dec 6
|
Pharma Stocks With Nice Dividends: The RX Investors Need
|
|
Dec 5
|
12 Best Healthcare Dividend Stocks To Buy Now
|
|
Dec 5
|
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
|
|
Dec 5
|
Here’s Why AbbVie (ABBV) Rose in Q3
|
|
Dec 4
|
Lilly (LLY) Gets Second FDA Nod for Lymphoma Drug Jaypirca
|
|
Dec 4
|
Optimism for AbbVie (NYSE:ABBV) has grown this past week, despite five-year decline in earnings
|